Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Savignoni

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|September 19, 2007
Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?B Sigal-Zafrani, M A Bollet, G Antoni, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 19, 2009
[Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]Y-M Kirova, L Caussa, B Granger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancerK I Cao, N Lebas, S Gerber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2011
[Management of inflammatory breast cancer after neo-adjuvant chemotherapy]S Abrous-Anane, A Savignoni, C Daveau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]C Daveau, A Savignoni, S Abrous-Anane, et al.
Eye (London, England)|October 3, 2015
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapyL Lumbroso-Le Rouic, I Aerts, D Hajage, et al.
Eye (London, England)|September 17, 2011
Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective studyP-R Rothschild, D Lévy, A Savignoni, et al.
Breast Cancer Research and Treatment|September 6, 2019
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie databaseE Kaczmarek, C Saint-Martin, J-Y Pierga, et al.
British Journal of Cancer|February 7, 2008
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategiesM A Bollet, A Savignoni, J-Y Pierga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2019
Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelinesC Collignon, M Carton, H J Brisse, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|September 19, 2007
Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?B Sigal-Zafrani, M A Bollet, G Antoni, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 19, 2009
[Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy]Y-M Kirova, L Caussa, B Granger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancerK I Cao, N Lebas, S Gerber, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2011
[Management of inflammatory breast cancer after neo-adjuvant chemotherapy]S Abrous-Anane, A Savignoni, C Daveau, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]C Daveau, A Savignoni, S Abrous-Anane, et al.
Eye (London, England)|October 3, 2015
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapyL Lumbroso-Le Rouic, I Aerts, D Hajage, et al.
Eye (London, England)|September 17, 2011
Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective studyP-R Rothschild, D Lévy, A Savignoni, et al.
Breast Cancer Research and Treatment|September 6, 2019
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie databaseE Kaczmarek, C Saint-Martin, J-Y Pierga, et al.
British Journal of Cancer|February 7, 2008
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategiesM A Bollet, A Savignoni, J-Y Pierga, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2019
Soft tissue sarcoma in children, adolescents and young adults: Outcomes according to compliance with international initial care guidelinesC Collignon, M Carton, H J Brisse, et al.
Pageof 3